<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="332">
  <stage>Registered</stage>
  <submitdate>30/08/2005</submitdate>
  <approvaldate>6/09/2005</approvaldate>
  <actrnumber>ACTRN12605000309684</actrnumber>
  <trial_identification>
    <studytitle>Quantifying the effect of nitrous oxide on the depth of anaesthesia using theoretically based time series modelling</studytitle>
    <scientifictitle>The effect of nitrous oxide on a new measure of anaesthetic depth during sevoflurane anaesthesia</scientifictitle>
    <utrn />
    <trialacronym>None</trialacronym>
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Anaesthetic depth and EEG changes</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patient randomised to 0% (control), 33% or 66% nitrous oxide during induction of anaethesia with sevoflurane.</interventions>
    <comparator>0% (control) nitrous oxide during induction of anaethesia with sevoflurane.</comparator>
    <control>Dose comparison</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The effect of nitrous oxide on the EEG during induction of anaesthesia with sevoflurane</outcome>
      <timepoint>The EEG is recorded continuously from the commencement of sevoflurane administration until loss of response to painful stimulation.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>None</outcome>
      <timepoint>No secondary outcome - no timepoint for secondary outcome.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Presenting for surgery, not at risk of gastrointestinal reflux during anaeshtesia, and without epilepsy or other EEG adnormalities.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No exclusion criteria</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Concealment in opaque envelopes</concealment>
    <sequence>Randomisation using computer generated random number list. No blocking or stratification</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Pharmacodynamics</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>1/01/2005</anticipatedstartdate>
    <actualstartdate>10/12/2004</actualstartdate>
    <anticipatedenddate />
    <actualenddate>16/09/2005</actualenddate>
    <samplesize>68</samplesize>
    <actualsamplesize>69</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Melbourne Health</primarysponsorname>
    <primarysponsoraddress>Royal Melbourne Hospital
Grattan St
Parkville Victoria 3050</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other Collaborative groups</fundingtype>
      <fundingname>ANZCA</fundingname>
      <fundingaddress>630 St Kilda Rd, Melbourne, VIC, 3004</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to determine the effects of nitrous oxide on the EEG, by randomising patients to inhaled induction of anaesthesia using nitrous oxide 33% or 66% or 0% with sevoflurane</summary>
    <trialwebsite />
    <publication>Liley DT, LESLIE K, Sinclair NC, Feckie M. Dissociating the effects of nitrous oxide on brain electrical activity using fixed order time series modeling. Computers in Biology and Medicine 2008: 38:1121-30</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Melbourne Hospital</ethicname>
      <ethicaddress>Parkville, VIC, 3050.</ethicaddress>
      <ethicapprovaldate>10/12/2004</ethicapprovaldate>
      <hrec>2004.109</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Associate Professor Kate Leslie</name>
      <address>Department of Anaesthesia and Pain Management
Royal Melbourne Hospital
Parkville VIC 3050</address>
      <phone>+61 3 93427000</phone>
      <fax>+61 3 93428623</fax>
      <email>kate.leslie@mh.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Associate Professor Kate Leslie</name>
      <address>Department of Anaesthesia and Pain Management
Royal Melbourne Hospital
Parkville VIC 3050</address>
      <phone>+61 3 93427000</phone>
      <fax>+61 3 93428623</fax>
      <email>kate.leslie@mh.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Associate Professor Kate Leslie</name>
      <address>Royal Melbourne Hospital, Parkville, VIC, 3050</address>
      <phone>+61 3 93427540</phone>
      <fax>+61 3 93428623</fax>
      <email>kate.leslie@mh.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Miss</title>
      <name>Kate Leslie</name>
      <address>Department of Anaesthesia and Pain Management
Royal Melbourne Hospital
Parkville VIC 3050
Australia
</address>
      <phone>61-418-374071</phone>
      <fax />
      <email>kate.leslie@mh.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>